Close Menu

NEW YORK ─ GenMark Diagnostics' CEO Scott Mendel on Thursday gave short shrift to a report that the firm has been approached by potential buyers and instead drew attention to the continuing high demand for its ePlex molecular diagnostics respiratory panel for coronavirus testing and the firm's belief that demand for the test will continue to grow for the foreseeable future.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.